Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the ona domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /home/risezcom/public_html/cord-blood.org.uk/wp-includes/functions.php on line 6170

Warning: Cannot modify header information - headers already sent by (output started at /home/risezcom/public_html/cord-blood.org.uk/wp-includes/functions.php:6170) in /home/risezcom/public_html/cord-blood.org.uk/wp-includes/feed-rss2.php on line 8
Business News Archives - Cord Blood https://cord-blood.org.uk/news/business-news/ and Stem Cell Banking Wed, 13 Mar 2024 12:01:03 +0000 en-GB hourly 1 https://wordpress.org/?v=7.0 Life-Saving Cells – The Booming Business of Cord Blood & Tissue Banking https://cord-blood.org.uk/life-saving-cells-the-booming-business-of-cord-blood-tissue-banking/?utm_source=rss&utm_medium=rss&utm_campaign=life-saving-cells-the-booming-business-of-cord-blood-tissue-banking Wed, 13 Mar 2024 12:01:02 +0000 https://cord-blood.org.uk/?p=899 The world has witnessed an incredible evolution in healthcare thanks to cord blood and tissue banking. This industry, which kick-started in the 1990s, has grown into a global powerhouse, controlling the fate of potentially life-saving treatments for countless diseases. The journey began in October 1988 with a groundbreaking procedure using cord blood-derived stem cells. Fast […]

The post Life-Saving Cells – The Booming Business of Cord Blood & Tissue Banking appeared first on Cord Blood.

]]> Global Stem Cell Banking to Grow by $6 Billion by 2030 https://cord-blood.org.uk/global-stem-cell-banking-to-grow-by-6-billion-by-2030/?utm_source=rss&utm_medium=rss&utm_campaign=global-stem-cell-banking-to-grow-by-6-billion-by-2030 Tue, 01 Aug 2023 14:18:00 +0000 https://cord-blood.org.uk/?p=502 The global stem cell banking market is expected to grow from $8 billion in 2022 to $14.3 billion by 2030. This essentially means that more and more people and institutions are investing in storing stem cells for future use. What are stem cells, and why are they important? Stem cells are the body’s raw materials […]

The post Global Stem Cell Banking to Grow by $6 Billion by 2030 appeared first on Cord Blood.

]]> Cryo-Cell Q2 2023 Financial Results Summary https://cord-blood.org.uk/cryo-cell-q2-2023-financial-results-summary/?utm_source=rss&utm_medium=rss&utm_campaign=cryo-cell-q2-2023-financial-results-summary Fri, 14 Jul 2023 10:18:00 +0000 https://cord-blood.org.uk/?p=439 Cryo-Cell International, a leader in cord blood banking, has announced its financial results for the second quarter of 2023. For those unfamiliar, cord blood banking involves collecting and storing the blood from a newborn’s umbilical cord, which contains valuable stem cells that can be used in medical treatments. What You Need to Know: A Quick […]

The post Cryo-Cell Q2 2023 Financial Results Summary appeared first on Cord Blood.

]]> U.S. Cord Blood Banking Services Market Will Benefit from Rising Awareness https://cord-blood.org.uk/u-s-cord-blood-banking-services-market-will-benefit-from-rising-awareness/?utm_source=rss&utm_medium=rss&utm_campaign=u-s-cord-blood-banking-services-market-will-benefit-from-rising-awareness Mon, 10 Jul 2023 09:56:00 +0000 https://cord-blood.org.uk/?p=411 According to a recent report, the U.S. cord blood banking services market is expected to reach a value of USD 16.59 billion by 2030, with a compound annual growth rate (CAGR) of 11.56%. Cord blood, which contains hematopoietic stem cells, has shown promising results in the treatment of certain diseases in children, such as hematologic […]

The post U.S. Cord Blood Banking Services Market Will Benefit from Rising Awareness appeared first on Cord Blood.

]]> The Growth of Biobanking https://cord-blood.org.uk/the-growth-of-biobanking/?utm_source=rss&utm_medium=rss&utm_campaign=the-growth-of-biobanking Wed, 05 Jul 2023 15:28:00 +0000 https://cord-blood.org.uk/?p=395 Biobanking is a rapidly growing industry that is expected to revolutionize healthcare. With increasing investments in regenerative medicine and personalized medicine, biobanks are becoming crucial for drug discovery and understanding the genetic basis of human diseases. The demand for medical data sets in biobanks has led to the rise of precision medicine, which aims to […]

The post The Growth of Biobanking appeared first on Cord Blood.

]]> Viera BioScience to unveil breakthrough stem cell therapy for heart diseases https://cord-blood.org.uk/viera-bioscience-to-unveil-breakthrough-stem-cell-therapy-for-heart-diseases/?utm_source=rss&utm_medium=rss&utm_campaign=viera-bioscience-to-unveil-breakthrough-stem-cell-therapy-for-heart-diseases Thu, 23 Feb 2017 15:20:00 +0000 http://cord-blood.org.uk/?p=205 Presentation: Viera BioScience will present at the 2017 Academy of Regenerative Practices Conference on February 25th. The talk will cover preclinical and clinical data of AngioMune, a cord blood derived product. Product: AngioMune is a “universal donor” T regulatory cell product that can stimulate angiogenesis, or new blood vessel formation. It has potential applications for […]

The post Viera BioScience to unveil breakthrough stem cell therapy for heart diseases appeared first on Cord Blood.

]]> Targazyme Secures US Patent for Breakthrough Cell Therapy Technology https://cord-blood.org.uk/targazyme-secures-us-patent-for-breakthrough-cell-therapy-technology/?utm_source=rss&utm_medium=rss&utm_campaign=targazyme-secures-us-patent-for-breakthrough-cell-therapy-technology Wed, 18 Jan 2017 13:30:00 +0000 http://cord-blood.org.uk/?p=185 Patent Award: Targazyme Inc., a biopharmaceutical company, has been awarded a US patent for fucosylation of various therapeutic cells to improve their targeting and homing to sites of tumors and inflammation. Fucosylation Technology: Fucosylation is an enzyme-based platform technology that treats therapeutic cells at the point-of-care before infusion into the patient. It aims to improve […]

The post Targazyme Secures US Patent for Breakthrough Cell Therapy Technology appeared first on Cord Blood.

]]>